Cleared Traditional

K012112 - RANDOX DIGITOXIN
(FDA 510(k) Clearance)

Jan 2002
Decision
189d
Days
Class 2
Risk

K012112 is an FDA 510(k) clearance for the RANDOX DIGITOXIN. This device is classified as a Enzyme Immunoassay, Digitoxin (Class II - Special Controls, product code LFM).

Submitted by Randox Laboratories, Ltd. (Crumlin, GB). The FDA issued a Cleared decision on January 11, 2002, 189 days after receiving the submission on July 6, 2001.

This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3300.

Submission Details

510(k) Number K012112 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 06, 2001
Decision Date January 11, 2002
Days to Decision 189 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Statement

Device Classification

Product Code LFM — Enzyme Immunoassay, Digitoxin
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3300

Similar Devices — LFM Enzyme Immunoassay, Digitoxin

All 19
DIMENSION VISTA DIGITOXIN, DIGOXIN, GENTAMICIN, N-ACETYLPROCAINAMIDE, PHENYTOIN, THEOPHYLLINE FLEX REAGENT CARTRIDGE
K062024 · Dade Behring, Inc. · Jul 2006
DGTX FLEX REAGENT CARTRIDGE, MODEL DF36
K990251 · Dade Behring, Inc. · Mar 1999
ACS DIGITOXIN
K970546 · Chiron Diagnostics Corp. · Jul 1997
ABBOTT AXSYM DIGITOXIN (MODIFY)
K963158 · Abbott Laboratories · Sep 1996
AXSYM DIGITOXIN
K954420 · Abbott Laboratories · Dec 1995
DIGOXIN ASSAY FOR THE TECCHNICON RA/OPERA SYSTEMS IN-VITRO DIAGNOSTIC SYSTEMS
K951631 · Bayer Corp. · Jun 1995